Cassava Sciences Announces Significant Program Progress and Expected Key Milestones in 2021 for Its Clinical Program in Alzheimer’s Disease

Go back to Cassava Sciences Announces Significant Program Progress and Expected Key Milestones in 2021 for Its Clinical Program in Alzheimer’s Disease
(NASDAQ: SAVA) Delayed: 40.92 +3.14 (8.31%)
Previous Close $37.78    52 Week High
Open $38.01    52 Week Low
Day High $41.19    P/E N/A 
Day Low $37.49    EPS
Volume 1,023,513